SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041303
Filing Date
2023-08-10
Accepted
2023-08-10 16:06:36
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elym-20230630.htm   iXBRL 10-Q 2763288
2 EX-31.1 elym-ex31_1.htm EX-31.1 21323
3 EX-32.1 elym-ex32_1.htm EX-32.1 12888
  Complete submission text file 0000950170-23-041303.txt   9596631

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elym-20230630_pre.xml EX-101.PRE 322409
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elym-20230630_lab.xml EX-101.LAB 433651
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elym-20230630_def.xml EX-101.DEF 154502
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elym-20230630_cal.xml EX-101.CAL 35298
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elym-20230630.xsd EX-101.SCH 56917
52 EXTRACTED XBRL INSTANCE DOCUMENT elym-20230630_htm.xml XML 2049258
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 231159323
SIC: 2834 Pharmaceutical Preparations